You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Medicated Skin Care in Romania

Oct 2011

Price: US$900

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Medicated Skin Care Market Research Report

doc_excel_table.png Sample Medicated Skin Care Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Medicated Skin Care industry in Romania with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Medicated Skin Care industry in Romania, our research will save you time and money while empowering you to make informed, profitable decisions.

The Medicated Skin Care in Romania market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Medicated Skin Care in Romania?
  • What are the major brands in Romania?
  • What are the most popular formats for acne treatments?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

TRENDS

  • Medicated skin care was characterised by differing performances across the various categories. The traditional categories of topical germicidals/antiseptics, topical antifungals and antipruritics continued to record low growth in 2010. The emerging categories of acne treatments, medicated shampoos, cold sore treatments, hair loss treatments, emollients/therapeutic moisturisers and antiparasitics/lice (head and body) treatments continued to register higher growth. This differing evolution was due to the wider availability of new products in the retail network, which encouraged a greater level of self-medication in the use of acne treatments, hair loss treatments, medicated shampoos and emollients, which are not perceived as genuine medicated skin care products and more as efficient cosmetics products.

COMPETITIVE LANDSCAPE

  • Antibiotice was the leader in medicated skin care in 2010 with a 13% value share, followed by Novartis Consumer Health. Antibiotice was the leading company in haemorrhoid treatments, topical antifungals and also in topical germicidals/antiseptics, as well as holding a leading position in vaginal antifungals, acne treatments, antipruritics and antiparasitics/lice (head and body) treatments. Its brand Hemorzon was the overall leading brand in medicated skin care in 2009, but the suppositories disappeared from the pharmacies for a few good months until production was restarted. Aside from the main domestic manufacturers, such as Antibiotice, Zentiva, Mark Pharmaceutics and Europharm, other Romanian companies held less significant shares of under 1%.

PROSPECTS

  • The constant value CAGR of 2% for medicated skin care will mainly be a result of changing Romanian consumer habits with the slow adoption of Western European lifestyles, which will boost the level of self-medication. However, the change will be more prominent for categories where the products are perceived as being closer to cosmetics than to medicated skin care. For some products, semi-ethical sales will be important, as consumers will continue to seek medical advice before using a treatment. Education for self-medication within the category will be an important factor that could lead to further growth.

Table of Contents

Table of Contents

Medicated Skin Care in Romania - Category Analysis

HEADLINES

TRENDS

  • Medicated skin care was characterised by differing performances across the various categories. The traditional categories of topical germicidals/antiseptics, topical antifungals and antipruritics continued to record low growth in 2010. The emerging categories of acne treatments, medicated shampoos, cold sore treatments, hair loss treatments, emollients/therapeutic moisturisers and antiparasitics/lice (head and body) treatments continued to register higher growth. This differing evolution was due to the wider availability of new products in the retail network, which encouraged a greater level of self-medication in the use of acne treatments, hair loss treatments, medicated shampoos and emollients, which are not perceived as genuine medicated skin care products and more as efficient cosmetics products.

SWITCHES

COMPETITIVE LANDSCAPE

  • Antibiotice was the leader in medicated skin care in 2010 with a 13% value share, followed by Novartis Consumer Health. Antibiotice was the leading company in haemorrhoid treatments, topical antifungals and also in topical germicidals/antiseptics, as well as holding a leading position in vaginal antifungals, acne treatments, antipruritics and antiparasitics/lice (head and body) treatments. Its brand Hemorzon was the overall leading brand in medicated skin care in 2009, but the suppositories disappeared from the pharmacies for a few good months until production was restarted. Aside from the main domestic manufacturers, such as Antibiotice, Zentiva, Mark Pharmaceutics and Europharm, other Romanian companies held less significant shares of under 1%.

PROSPECTS

  • The constant value CAGR of 2% for medicated skin care will mainly be a result of changing Romanian consumer habits with the slow adoption of Western European lifestyles, which will boost the level of self-medication. However, the change will be more prominent for categories where the products are perceived as being closer to cosmetics than to medicated skin care. For some products, semi-ethical sales will be important, as consumers will continue to seek medical advice before using a treatment. Education for self-medication within the category will be an important factor that could lead to further growth.

CATEGORY DATA

  • Table 1 Sales of Medicated Skin Care by Category: Value 2005-2010
  • Table 2 Sales of Medicated Skin Care by Category: % Value Growth 2005-2010
  • Table 3 Acne Treatments by Format: % Value Breakdown 2005-2010
  • Table 4 Medicated Skin Care Company Shares by Value 2006-2010
  • Table 5 Medicated Skin Care Brand Shares by Value 2007-2010
  • Table 6 Acne Treatments Brand Shares by Value 2007-2010
  • Table 7 Hair Loss Treatments Brand Shares by Value 2007-2010
  • Table 8 Forecast Sales of Medicated Skin Care by Category: Value 2010-2015
  • Table 9 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2010-2015

Medicated Skin Care in Romania - Company Profiles

Antibiotice SA in Consumer Health (Romania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 3 Antibiotice SA: Competitive Position 2010

Biofarm SA in Consumer Health (Romania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Biofarm SA: Competitive Position 2010

Ozone Laboratories SRL in Consumer Health (Romania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 9 Ozone Laboratories SRL: Competitive Position 2010

Terapia Ranbaxy in Consumer Health (Romania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 12 Terapia Ranbaxy: Competitive Position 2010

Zentiva SA in Consumer Health (Romania)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 15 Zentiva SA: Competitive Position 2010

Consumer Health in Romania - Industry Context

EXECUTIVE SUMMARY

The market continues growing in 2010, despite economic hardship

Per capita expenses for health remain among the lowest in Europe

Foreign and local companies go shoulder-to-shoulder in terms of market share

Chemists/pharmacies maintain the leading position

Healthcare consumption is expected to register solid and steady growth

KEY TRENDS AND DEVELOPMENTS

Rural areas represent strong growth potential

Ageing population impacts consumer healthcare's performance

Changes in consumer lifestyle encourages consumption

Consumer healthcare remains highly regulated

Modernisation of pharmacies contributes to sales growth

Qualitative loss in the National Health System affects pharmaceutical market

MARKET INDICATORS

  • Table 10 Consumer Expenditure on Health Goods and Medical Services 2005-2010
  • Table 11 Life Expectancy at Birth 2005-2010

MARKET DATA

  • Table 12 Sales of Consumer Health by Category: Value 2005-2010
  • Table 13 Sales of Consumer Health by Category: % Value Growth 2005-2010
  • Table 14 Consumer Health Company Shares by Value 2006-2010
  • Table 15 Consumer Health Brand Shares by Value 2007-2010
  • Table 16 Sales of Consumer Health by Distribution Format: % Analysis 2005-2010
  • Table 17 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 18 Forecast Sales of Consumer Health by Category: Value 2010-2015
  • Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2010-2015

APPENDIX

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/Self-Care and Preventative Medicine

Switches

  • Summary 16 OTC Healthcare Switches 2008-2010

DEFINITIONS

  • Summary 17 Research Sources

Segmentation

Segmentation

This market research report includes the following:

  • Medicated Skin Care
    • Acne Treatments
    • Medicated Shampoos
    • Topical Antifungals
    • Vaginal Antifungals
    • Hair Loss Treatments
    • Nappy (Diaper) Rash Treatments
    • Antiparasitics/Lice (Head and Body) Treatments
    • Antipruritics
    • Child-Specific Medicated Skin Care
    • Cold Sore Treatments
    • Haemorrhoid Treatments
    • Topical Allergy Remedies/Antihistamines
    • Topical Germicidals/Antiseptics

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!

RELATED

Country Report

Consumer Lifestyle

Country Report

Future Demographic